[1]王国艳,孔祥斌,高 阳.熊去氧胆酸联合蓝光治疗新生儿高胆红素血症疗效的Meta分析[J].医学信息,2023,36(17):34-39.[doi:10.3969/j.issn.1006-1959.2023.17.006]
　WANG Guo-yan,KONG Xiang-bin,GAO Yang.Meta-analysis of the Efficacy of Ursodeoxycholic Acid Combined with Blue Light in the Treatment of Neonatal Hyperbilirubinemia[J].Journal of Medical Information,2023,36(17):34-39.[doi:10.3969/j.issn.1006-1959.2023.17.006]
点击复制

熊去氧胆酸联合蓝光治疗新生儿高胆红素血症疗效的Meta分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年17期
页码:
34-39
栏目:
医学数据科学
出版日期:
2023-09-01

文章信息/Info

Title:
Meta-analysis of the Efficacy of Ursodeoxycholic Acid Combined with Blue Light in the Treatment of Neonatal Hyperbilirubinemia
文章编号:
1006-1959（2023）17-0034-06
作者:
王国艳; 孔祥斌; 高 阳
（临沂市中心医院耳鼻咽喉科1，儿科2，山东 临沂 276400）
Author(s):
WANG Guo-yan; KONG Xiang-bin; GAO Yang
(Department of Otolaryngology1,Department of Pediatrics2,Linyi Central Hospital,Linyi 276400,Shandong,China)
关键词:
熊去氧胆酸; 高胆红素血症; 新生儿; 蓝光
Keywords:
Ursodeoxycholicacid; Hyperbilirubinemia; Newborn; Blue light
分类号:
R179
DOI:
10.3969/j.issn.1006-1959.2023.17.006
文献标志码:
A
摘要:
目的 系统评价熊去氧胆酸（UDCA）联合蓝光对新生儿高胆红素血症的治疗效果。方法 检索PubMed、EMbase、Web of Science、Cochrane图书馆、中国期刊全文数据库（CNKI）、万方数据库（Wanfang）和中国国生物医学文献数据库（SinoMed）有关熊去氧胆酸联合蓝光治疗新生儿高胆红素血症的临床随机对照研究，检索时间自建库至2021年2月。对符合标准的研究进行质量评价，并应用RevMan5.4软件进行Meta分析。结果 共纳入随机对照研究4篇，共400例新生儿，其中熊去氧胆酸组198例，对照组202例。Meta分析结果显示，熊去氧胆酸组治疗12 h（MD=-2.37，95%CI：-3.10~-1.64）、24 h（MD=-2.95，95%CI：-3.88~-2.02）总胆红素值低于对照组，差异有统计学意义（P＜0.000 01）；熊去氧胆酸组治疗48 h总胆红素低于对照组（MD=-2.46，95%CI：-4.98~0.06），但差异无统计学意义（P＞0.05）；熊去氧胆酸组总光疗时长短于对照组（SMD=-2.70，95%CI：-3.01~-2.40），差异有统计学意义（P＜0.000 01）。结论 熊去氧胆酸联合蓝光治疗对于新生儿高胆红素血症患儿具有较好的疗效，但该结论仍需大量多中心的随机对照研究进一步证实。
Abstract:
Objective To systematically evaluate the therapeutic effect of ursodeoxycholic acid (UDCA) combined with blue light on neonatal hyperbilirubinemia.Methods PubMed, EMbase, Web of Science, Cochrane Library, Chinese Journal Full-text Database (CNKI), Wanfang Database and Chinese Biomedical Literature Database (SinoMed) were searched for clinical randomized controlled studies on ursodeoxycholic acid combined with blue light in the treatment of neonatal hyperbilirubinemia. The retrieval time was from the establishment of the database to February 2021. The quality of the studies that met the criteria was evaluated, and meta-analysis was performed using RevMan 5.4 software.Results A total of 4 randomized controlled studies were included, with a total of 400 newborns, including 198 newborns in the ursodeoxycholic acid group and 202 newborns in the control group. The results of Meta-analysis showed that the total bilirubin value of 12 h (MD=-2.37,95%CI:-3.10 to -1.64) and 24 h (MD=-2.95,95%CI:-3.88 to -2.02) in the ursodeoxycholic acid group was lower than that in the control group, and the difference was statistically significant (P<0.000 01);the total bilirubin in the ursodeoxycholic acid group was lower than that in the control group at 48 h (MD=-2.46,95%CI:-4.98 to 0.06), but the difference was not statistically significant (P>0.05)； the total duration of phototherapy in the ursodeoxycholic acid group was shorter than that in the control group (SMD=-2.70,95%CI:-3.01 to -2.40), and the difference was statistically significant (P<0.000 01).Conclusion Ursodeoxycholic acid combined with blue light therapy has a good effect on neonatal hyperbilirubinemia, but this conclusion still needs to be further confirmed by a large number of multi-center randomized controlled studies.

参考文献/References:

[1]Chen KW,Yuan TM.The role of microbiota in neonatal hyperbilirubinemia[J].Am J Transl Res,2020,12(11):7459-7474.[2]Karimzadeh P,Fallahi M,Kazemian M,et al.Bilirubin induced encephalopathy[J].Iran J Child Neurol,2020,14(1):7-19.[3]Zhang L.Severe neonatal hyperbilirubinemia induces temporal and occipital lobe seizures[J].PLoS One 2018,13(5):e0197113.[4]Morioka I.Hyperbilirubinemia in preterm infants in Japan: new treatment criteria[J].Pediatr Int,2018,60(8):684-690.[5]Hansen TWR,Maisels MJ,Ebbesen F,et al.Sixty years of phototherapy for neonatal jaundice-from serendipitous observation to standardized treatment and rescue for millions[J].J Perinatol,2020,40(2):180-193.[6]Olusanya BO,Kaplan M,Hansen TWR.Neonatal hyperbilirubinaemia: a global perspective[J].Lancet Child Adolesc Health, 2018,2(8):610-620.[7]Anderson NB,Calkins KL.Neonatal indirect hyperbilirubinemia[J].Neo Reviews,2020,21(11):e749-e760.[8]Wang J,Guo GX,Li AM,et al.Challenges of phototherapy for neonatal hyperbilirubinemia (review) [J].Exp Ther Med,2021,21(3):231.[9]Faulhaber FRS,Procianoy RS,Silveira RC.Side effects of phototherapy on neonates[J].Am J Perinatol,2019,36(3):252-257.[10]George R,Stevens A,Berkenbosch JW,et al.Ursodeoxycholic acid in the treatment of cholestasis and hyperbilirubinemia in pediatric intensive care unit patients[J].South Med J,2002,95(11):1276-1279.[11]Garzón L,Ledo A,Cubells E,et al.Cholestasis associated with prolonged parenteral nutrition in neonates: the role of urso-deoxycholic acid[J].An Pediatr (Barc),2009,70(6):547-552.[12]Simental-Mendía M,Sánchez-García A,Simental-Mendía LE.Effect of ursodeoxycholic acid on liver markers: a systematic review and meta-analysis of randomized placebo-controlled clinical trials[J].Br J Clin Pharmacol,2020,86(8):1476-1488.[13]Mohamed I,Thibault M,Malo J,et al.O-084 Ursodeoxycholic acid for parenteral nutrition associated liver disease in neonates: arandomised controlled pilot study[J].Arch Dis Child,2014,99(Suppl 2):A56.2-A57.[14]Malik D,Khan SH,Ali SW,et al.Comparison of phenobarbitone and ursodeoxycholic acid in drug-augmented hepatobiliary scintigraphy for excluding the diagnosis of obstructive cholestasis in neonatal cholestasis syndrome[J].Nucl Med Commun,2015,36(8):827-832.[15]Cuperus FJ,Hafkamp AM,Havinga R,et al.Effective treatment of unconjugated hyperbilirubinemia with oral bile salts in Gunn rats[J].Gastroenterology,2009,136(2):673-682.e1.[16]杨松媚,梁玉美,冯燕妮,等.熊去氧胆酸联合双歧杆菌四联活菌片对高胆红素血症新生儿心肌酶、免疫功能及炎症反应的影响[J].海南医学院学报,2018,24(7):773-776.[17]吴文旭,梁艺耀,林捷,等.蓝光联合熊去氧胆酸治疗新生儿病理性黄疸的效果观察[J].实用临床医学,2017,18(5):67-69.[18]Hassan A,Abdulrahman A,Husain R.Effect of Ursodeoxycholic Acid in Lowering Neonatal Indirect Hyperbilirubinemia: a Randomized controlled trial[J].Merit Research Journal of Medicine and Medical Sciences,2015,3(9):402-405.[19]Gharehbaghi MM,Sani AM,Refeey M.Evaluating the effects of different doses of ursodeoxycholic acid on neonatal jaundice[J].Turk J Pediatr,2020,62(3):424.[20]Honar N,Ghashghaei Saadi E,Saki F,et al.Effect of ursodeoxycholicacid on indirect hyperbilirubinemia in neonates treated with phototherapy[J].J Pediatr Gastroenterol Nutr,2016,62(1):97-100.[21]Ughasoro MD,Adimorah GN,Chukwudi NK,et al.Reductive effect of ursodeoxycholic acid on bilirubin levels in neonates on phototherapy[J].Clin Exp Gastroenterol,2019,12:349-354.[22]Lee B,Piersante T,Calkins KL.Neonatal hyperbilirubinemia[J].Pediatr Ann,2022,51(6):e219-e227.[23]Pan DH,Rivas Y.Jaundice: newborn to age 2 months[J].Pediatr Rev,2017,38(11):499-510.[24]Ahlfors CE,Bhutani VK,Wong RJ,et al.Bilirubin binding in jaundiced newborns: from bench to bedside?[J].Pediatr Res,2018,84(4):494-498.[25]Qattea I,Farghaly MAA,Elgendy M,et al.Neonatal hyperbilirubinemia and bilirubin neurotoxicity in hospitalized neonates: analysis of the US database[J].Pediatr Res,2022,91(7):1662-1668.[26]Hammerman C,Kaplan M.Hyperbilirubinemia in the term infant: re-evaluating what we think we know[J].Clin Perinatol,2021,48(3):533-554.[27]Du LZ,Ma XL,Shen XX,et al.Neonatal hyperbilirubinemia management: clinical assessment of bilirubin production[J].Semin Perinatol,2021,45(1):151351.[28]Olusanya BO,Teeple S,Kassebaum NJ.The contribution of neonatal jaundice to global child mortality: findings from the GBD 2016 study[J].Pediatrics,2018,141(2):e20171471.[29]Lin Q,Zhu DM,Chen CH,et al.Risk factors for neonatal hyperbilirubinemia: a systematic review and meta-analysis[J].Transl Pediatr,2022,11(6):1001-1009.[30]Pillai A,Pandita A,Osiovich H,et al.Pathogenesis and management of indirect hyperbilirubinemia in preterm neonates less than 35 weeks: moving toward a standardized approach[J].Neoreviews,2020,21(5):e298-e307.[31]张震海,方晓燕.高胆红素血症新生儿发生胆红素脑病的危险因素[J].中外医学研究,2021,19(24):27-29.[32]Amin SB,Smith T,Timler G.Developmental influence of unconjugated hyperbilirubinemia and neurobehavioral disorders[J].Pediatr Res,2019,85(2):191-197.[33]Akefi R,Hashemi SM,Alinejad S,et al.The effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy: a randomized clinical trial[J].J Matern Fetal Neonatal Med,2022,35(21):4075-4080.[34]Chu LL,Xue XJ,Qiao JH.Efficacy of intermittent phototherapy versus continuous phototherapy for treatment of neonatal hyperbilirubinaemia: asystematic review and meta-analysis[J].J Adv Nurs,2021,77(1):12-22.[35]Alkén J,H?覽kansson S,Ekéus C,et al.Rates of extreme neonatal hyperbilirubinemia and kernicterus in children and adherence to national guidelines for screening, diagnosis, and treatment in Sweden[J].JAMA Netw Open,2019,2(3):e190858.[36]Rezaie M,Gholami R,Jafari M,et al.Evaluating the effect of ursodeoxycholic acid on total bilirubin of neonates with glucose-6-phosphate dehydrogenase deficiency complicated by indirect hyperbilirubinaemia[J].J Paediatr Child Health,2021,57(8):1175-1181.[37]Liu SY,Chang LW,Wang J,et al.Ursodeoxycholic acid prevention on cholestasis associated with total parenteral nutrition in preterm infants: a randomized trial[J].World J Pediatr,2022,18(2):100-108.[38]Zeng LM,Li M,Cen YT,et al.Effects of S-adenosyl-L-methionine combined with ursodesoxycholicacid on serum endotoxin, MMP-9 and IL-18 in neonates with cholestasis[J].J Coll Physicians Surg Pak,2021,31(12):1445-1448.

相似文献/References:

[1]邬 剑,李慧玲.血清NSE及UCB检测新生儿高胆红素血症脑损伤的价值[J].医学信息,2018,31(15):158.[doi:10.3969/j.issn.1006-1959.2018.15.052]
　WU Jian,LI Hui-ling.The Value of Serum NSE and UCB in Detecting Brain Injury in Neonates with Hyperbilirubinemia[J].Journal of Medical Information,2018,31(17):158.[doi:10.3969/j.issn.1006-1959.2018.15.052]
[2]周宏芳.熊去氧胆酸治疗妊娠期肝内胆汁淤积症患者的临床疗效及对母婴结局的影响[J].医学信息,2022,35(16):94.[doi:10.3969/j.issn.1006-1959.2022.16.022]
　ZHOU Hong-fang.Clinical Effect of Ursodeoxycholic Acid in Treatment of Patients with Intrahepatic Cholestasis of Pregnancy and its Influence on Maternal and Infant Outcomes[J].Journal of Medical Information,2022,35(17):94.[doi:10.3969/j.issn.1006-1959.2022.16.022]
[3]杨 帅.酪酸梭菌活菌散剂在治疗新生儿高胆红素血症中的作用[J].医学信息,2019,32(23):147.[doi:10.3969/j.issn.1006-1959.2019.23.045]
　YANG Shuai.The Role of Clostridium Butyricum Powder in the Treatment of Neonatal Hyperbilirubinemia[J].Journal of Medical Information,2019,32(17):147.[doi:10.3969/j.issn.1006-1959.2019.23.045]

更新日期/Last Update: 1900-01-01